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http://www.biomedcentral.com/1471-2261/14/39RESEARCH ARTICLE Open AccessUrine π-Glutathion S-transferase but not
Tamm-Horsfall protein correlates with Carotid
artery intima media thickness in childhood
type1 diabetes
Peter Holmquist1* and Petru Liuba2Abstract
Background: Renal disease remains a serious threat in patients with insulin-dependent (type1) diabetes. Hence its
detection early in the life of patients with type1 diabetes is crucial. Several lines of evidence suggest similar
mechanisms for the development of both renal and arterial disease. We sought to investigate in young patients
with type1 diabetes whether π-Glutathione S-transferase to creatinine (π-GST:crea) and Tamm-Horsfall protein to
creatinine (THP:crea) ratios, markers of distal tubular renal function, relate to subclinical markers of arterial disease,
which appear to onset early and develop rapidly in type1 diabetes.
Methods: Seventy-one children and adolescents (median age and diabetes duration 14 and 6 years, respectively)
with type1 diabetes for at least 6 months were assessed for timed urine levels of π-GST, THP, HbA1c, albumin, and
plasma C-reactive protein (CRP). Carotid artery intima-media thickness (IMT), brachial artery flow-mediated dilatation
(FMD), and cutaneous microvascular function were assessed by high-resolution ultrasound and laser Doppler,
respectively.
Results: Two patients had microalbuminuria (> 20 μg/min), and were therefore removed from the study
population. π-GST:crea ratio and THP:crea showed no relationship to the demographic, diabetes, or inflammatory
indices. Lower π-GST:crea ratio was associated with greater IMT (p = 0.01, r = −0.29), particularly in female patients
(p = 0.004, r = −0.49). The association of π-GST:crea ratio with IMT was stronger in patients with passive smoke
exposure (p = 0.002, r = −0.43). Among post-pubertal patients, lower π-GST:crea ratio was also associated with lower
microvascular response to Ach (acetylcholine; p = 0.03, r = 0.49).
Conclusions: In young patients with type1 diabetes, proximal tubular dysfunction as suggested by lower levels
of π-GST:crea ratio seems to be paralleled by changes in arterial structure and microvascular function.
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Functional and structural arterial abnormalities occur
early in the life of patients with type1 diabetes [1-3].
Thickening of the arterial wall and functional distur-
bances in the arterial endothelium, which are more
prevalent in type 1 diabetes particularly when other risk
factors such as smoke exposure are present [1], may be* Correspondence: Peter.Holmquist@med.lu.se
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article, unless otherwise stated.detected without any clear relation to the degree of
glycemic control [4]. Although subtle, these changes
may be detected non-invasively via high-resolution ultra-
sound and are seemingly at least in part responsible for
the increased prevalence of cardiovascular disease in
adult life [2].
In the kidney, microvascular dysfunction is thought to
contribute to tubular injury [3]. Albuminuria is still the
accepted standard in the diagnosis of nephropathy, and
in some but not all studies was found to be associated
with vascular changes [5,6]. Microalbuminuria, however,Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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patients [7].
Novel urine biomarkers specific for different parts of the
kidney have been tested for early diagnosis of nephropathy
[7,8]. One of these, π-GST, is localized in the cytoplasm in
both podocytes and parietal epithelial cells of Bowmans
capsule and mostly in the distal convoluted and medullary
tubules and collecting ducts [9]. Recent study showed that
π-GST is also expressed in aortic endothelial cells [10],
and may protect vascular endothelium against noxious
stimuli. In adult patients, it has been found to be a pre-
dictor of kidney injury with increasing albuminuria [7]. In
a male cohort of pediatric patients with type1 diabetes,
π-GST:crea ratio was decreased [11], but increase has
been reported after cardiac surgery [12].
Another putative marker of tubular dysfunction, Tamm-
Horsfall protein (THP), is located in the thick ascending
limb of the loops of Henle and the distal tubular cells [13],
Its urine excretion is largely regulated by sodium intake
[14]. Abnormal urine excretion of THP is found already at
diagnosis of type1 diabetes in children [8]. An association
between cardiovascular mortality and decreased levels of
urine THP in adult type1 patients has been reported [15].
Our aim was to assess whether urine levels of π-GST:
crea ratio and THP:crea are associated in young patients
with type 1 diabetes with changes in vascular structure
and function.
Subjects
Of the 184 children with type1 diabetes (duration >
6 months) enrolled in a previous study on urine excretion
of GST enzymes [16], 71 were included in another study
carried out within the same timeframe investigating vas-
cular (carotid artery intima media thickness (IMT), and
skin microvascular endothelial function) and inflamma-
tory (C-reactive protein (CRP)) parameters. Exposure to
environmental tobacco smoke (ETS) was assessed via
questionnaire [1], and defined as occasional or regular
cigarette smoking in the presence of study participants in
or outside home (e.g. private or public transportation, in
or around school, playground, other public places). Pa-
tients were divided into three groups: 1 = no exposure
during the past year; 2 = occasional exposure, i.e. presence
in a smoky environment less than once a week; 3 = weekly
to daily exposure. In addition the average number of
cigarettes smoked per day in or around home by patient’s
cohabitants was assessed as well as the number of house-
hold smokers.
Our patients are routinely treated with insulin Glargin
once daily or insulin Detemir twice daily and direct-
acting insulin Aspart with meals. In this cohort, nearly
15% of the diabetic children used an insulin pump with
direct-acting insulin. HbA1c and blood pressure were
measured four times a year upon follow-up visits.Exclusion criteria were age below 6 years, familial hyper-
cholesterolemia, active smoking, systemic hypertension,
and albuminuria (urine albumin > 20 μg/min). The ethical
committee for human research at the Lund University
Hospital approved the study (571/2004). Written and oral
consent was obtained from all participants and or parents.
Methods
Urine and blood analyses
The method for urine π-GST analysis is described else-
where [11]. Timed-over-night urine was collected at home.
A specimen of urine for GST was spared with the addition
of a preservative provided by the manufacturer (Biotrin
International Ltd, Dublin, Ireland). Seventy-one π-GST
urine tests were analyzed with a commercially available
solid phase sandwich, immunosorbent assay from Biotrin
International Ltd, Dublin, Ireland. HbA1c was measured by
a high performance linked liquid chromatography (HPLC,
Auto-A, Tosoh) with a normal value of 4–5.3%. U-crea-
tinine was measured by an enzymatic calorimetric method
(Hitachi Modular-P) with detection limit 0.03 mmol/L
(range 0.03-53 mmol/L). Urine Tamm-Horsfall protein
[17] and albumin [18] were measured by ELISA as previ-
ously described. Plasma high sensitive C reactive protein
(CRP) was measured by enzyme-linked immunoassay
using polyclonal antibodies (DACO Diagnostics, Glostrup,
Denmark). Plasma cystatin C was measured by an auto-
mated particle enhanced immunoturbidimetric method
with normal range of 0.55-1.15 mg/L [19]. Plasma crea-
tinine was analysed by a creatininase enzyme-based ana-
lyse system (Hitachi Modular-P) with detection limit of
2.7 μmol/L and a normal value between 5–15 years 25–68,
male 60–105 and female 45–90 μmol/L. All children had
their height and weight measured. Blood pressure was
taken in supine position after 5-minute rest with an arm
cuff covering two third of the right upper arm.
Assessment of carotid artery intima-media thickness
Longitudinal scans in bidimensional mode of the 1-cm
long distal end of the left common carotid artery were
imaged so that the lumen-intima and intima-media in-
terfaces were clearly distinguishable. All scans corre-
sponded to the R-wave on the ECG. Four to six scans
from each individual were recorded on videotape for off
line analyses of the carotid artery compliance, stiffness
index and intima media thickness IMT). The mean ca-
rotid IMT of four measurements along a 1-cm segment
was calculated from each scan. Mean IMT values ob-
tained from all scans from the same subject were aver-
aged, and the resulted mean IMT was used for statistical
analyses. All scans were taken by a single sonographist,
and the analyses were performed blind to the patients’
characteristics. The intraobserver variability coefficient
was less than 5%.
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iontophoresis
Cutaneous blood flow responses to endothelium-dependent
and independent agonists were assessed by using a laser
Doppler multifiber probe (481–1; Perimed AB, Sweden)
during transdermal iontophoresis of acetylcholine (Ach)
and sodium nitroprusside (SNP), respectively, on the volar
side of the forearm. The nondominant upper extremity
was chosen in all patients. Anodal iontophoresis was used
for Ach, whereas SNP was delivered via cathodal ionto-
phoresis. The current was set at 100 μA for 20 s for both
drugs, based on previous work [20]. Five consecutive
doses were applied for both drugs to generate dose–re-
sponse curves. Baseline perfusion and changes in response
to Ach were expressed as area under the curve. The
intraobserver variability for skin responses to acetylcho-
line was 10.4%.
Statistics
Results are given as median and range for variables with
skewed distribution (see below), and as mean and stan-
dard deviations for those variables with Gaussian distri-
bution. Spearman’s correlation coefficient and analysis of
variance (ANOVA) followed when applicable (i.e. signifi-
cant p value) by Bonferroni posthoc test were used to as-
sess the differences between the groups. When variable’s
distribution was skewed, log-transformation was used be-
fore being entered into the analysis. For statistical purpose
(calculation and graphing), patients with π-GST below the
detection limit were assigned a value of 0.05 ng/ml. Ad-
justment for co-variables was done with ANCOVA. Sig-
nificance was accepted when p ≤0.05. All analyses were
performed using the Stat View for Windows as statistical
package (USA).Table 1 Descriptive data of the studied cohort
Mean Std. Dev Count
Age (years) 14.7 3.5 69
BMI (kg/m2) 20.9 3.2 69
Diabetes Duration (years) 6.9 4.2 69
HbA1c (%) 6.9 1.3 69
Systolic BP (mm Hg) 112.8 10.9 69
Diastolic BP (mm Hg) 70.6 6.7 69
AER (ug/min) 2.9 2.3 69
Urine THP: creatinine ratio .9 .9 69
Urine π-GST: creatinine ratio .5 .9 68
Cystatin C (mg/L) .8 .1 67
GFR (ml/min) 145.1 47.6 67
CRP (mg/L) 1.8 3.2 68
IQR: interquartile range; BMI: body mass index; HbA1c: glycosylated hemoglobin; BP
π-GST: π-Glutathione S-transferase to creatinine; GFR: glomerular filtration rate; CRPCalculations
Urinary excretion rates were calculated in relation to
1.73 m2 body surface area (= Weight0.425 × Height0.725 ×
71.84/100) to adjust for size and gender. The ratio between
the urine component and urine creatinine was used to cor-
rect for failures in timed collections. Cystatin C clearance
was used to estimate glomerular filtration rate (GFR; ml/
min/1.73 m2 body surface area) = 84.69 * cystatin C (mg/L)
and * 1.384 for children < 14 years [21]. Urine π-GST:crea
ratio below 0.03 or above 1.88 μg/mmol the lowest and the
highest, respectively, in the control material, was consi-
dered abnormal [11].Results
π-GST:crea ratio was available in 71 patients. Data from
two patients were discarded due to microalbuminuria
(urine albumin > 20 μg/min). Demographic, diabetes, in-
flammatory, metabolic and renal function indexes in the
remaining 69 patients are given in Table 1.Urine albumin excretion
With the exception of the two aforementioned patients,
urine albumin was within normal range. Neither plasma
cystatin C nor GFR (cystatin C clearance) showed signs
of overt renal disease (Table 1). Albumin excretion rate
(AER) rose with increasing age (p = 0.008, r = 0.31) and
diabetes duration (p = 0.017, r = 0.29), but remained within
normal range in all patients (Table 1). Neither π-GST:crea
ratio nor THP:crea correlated with AER (p > 0.2). HbA1c
showed no association with AER (p = 0.6), whereas pa-
tients without ETS (group 1) tended to have lower AER
than those with regular ETS (group 3; p = 0.05, adjusted
for age via ANCOVA).Minimum Maximum Skewness Median IQR
7.0 20.0 -.3 14.0 5.0
14.9 28.6 .2 20.8 4.9
.5 18.0 .4 6.0 6.0
3.9 11.2 .5 67 1.6
81.0 139.0 -.1 70.0 8.0
53.0 89.0 -.1 70.0 8.0
.3 11.8 2.0 2.3 2.3
.0 4.4 2.0 .6 .8
.0 6.0 4.4 .3 .6
.4 1.1 -.6 .8 .2
79.0 373.0 2.1 141.0 43.8
.1 13.3 2.3 .5 1.4
: blood pressure; AER: albumin excretion rate; THP: Tamm-Horsfall protein;
: C-reactive protein.
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THP:crea ratio, a distal tubular marker of nephropathy,
showed no relationship with any of the studied kidney
and vascular markers (p > 0.2). Also, there was no corre-
lation between THP:crea and π-GST:crea ratios (p = 0.4).
Urine π-GST to creatinine ratio
Among patients, π-GST:crea ratio was lower in males
than in females (p < 0.01). There was a weak correlation
between π-GST:crea ratio and GFR (p = 0.02, r = 0.3).
Neither the degree of glycemic control, as expressed by
HbA1c, nor the age or diabetes duration, correlated with
π-GST:crea ratio (p > 0.4). CRP showed a weak corre-
lation with π-GST:crea ratio (p = 0.03, r = 0.26).
Lower π-GST:crea ratio was associated with greater
IMT (p = 0.01, r = −0.29; Figure 1/Panel A), particularly
in female patients (p = 0.004, r = −0.49). The association
of π-GST:crea ratio with IMT became stronger in pa-
tients with ETS (p = 0.002, r = −0.43; Figure 1/Panel B).
Among post-pubertal patients (>14 years of age), lowerFigure 1 Relationship of urine π-GST:crea ratio (log-transformed) with
cohort of patients; Panel B: in patients with exposure to tobacco smoke.π-GST:crea ratio was associated with lower microvascu-
lar response to acetylcholine (Ach; p = 0.03, r = 0.49;
Figure 2). The responses to SNP showed no correlation
with π-GST:crea ratio levels (p > 0.5).
Discussion
Using a cross-sectional design, we observed in a relatively
small cohort of young patients with type1 diabetes several
associations between lower urine levels of π-GST:crea
ratio and adverse changes in carotid artery structure and
cutaneous microvascular function. Female gender and
exposure to tobacco smoke appear to strengthen this asso-
ciation. This is in keeping with some previous studies
showing that girls with type1 diabetes are more prone to
atherosclerosis development [22], and that exposure to to-
bacco smoke further increases cardiovascular risk among
type1 diabetes patients [23].
The development of renal disease in type1 diabetes is
often subtle especially in younger patients. The test re-
commended by the American Diabetes Association forcarotid artery intima-media thickness (IMT). Panel A: in the whole
Figure 2 Relationship of urine π-GST:crea ratio (log-transformed) with mean cutaneous response to acetylcholine (Ach) among
postpubertal patients (age ≥14 years).
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urinary albumin:creatinine ratio; however, this test per-
forms poorly, with relatively low sensitivity and low spe-
cificity (7).
In view of the previous studies suggesting that vascular
and kidney disease in type1 diabetes progress hand in
hand [24,25], the association of π-GST, a novel marker of
kidney disease, with increased carotid artery intima-media
thickness and cutaneous microvascular dysfunction in the
present study is perhaps not surprising. These two adverse
vascular changes have been shown to develop early after
the onset of type1 diabetes [26]. Abnormalities in peri-
pheral arterial function and structure have been docu-
mented in both pediatric and adult cohorts with renal
disease [3,27], suggesting a complex “cross-talk” between
the vascular system and the kidney [28].
With the exception of this study, to the best of our
knowledge, there are no further reports on π-GST:crea
ratio in a pediatric population. In adult diabetic patients,
urinary π-GST:crea ratio was found to rise with increa-
sing albuminuria [7]. A similar trend was observed in
adult patients with overt renal disease [13]. The cohort
included in the present study is much younger and free
of albuminuria, and was earlier found to have lower
levels of π-GST:crea ratio than in healthy controls [11].
Whether age, diabetes duration, and/or stage of kidney
injury could influence the urine levels of π-GST remains
to be assessed in future studies. Maybe, since the origin
of π-GST is renal, there is a bimodal response of kidney
π-GST:crea ratio to diabetic kidney injury with an early
decrease followed by increase as microalbuminuria
occurs.
We noted a weak correlation of π-GST:crea ratio with
the inflammatory marker CRP. Smoke exposure, diabetes
duration, and poor diabetes control (HbA1c), may all be
involved in the onset and progression of endothelialdamage in type1 diabetes, with release of inflammatory
mediators [4,29]. Intuitively sustained injury to the vessel
wall could provide a potential substrate for injury to renal
tubules [30]. This could in turn, over time, lead to increase
in π-GST excretion. Alternatively, these two processes
could be unrelated to each other, although, at least based
on our findings suggesting some association between π-
GST and IMT, a common mechanism seemingly related
to the diabetes milieu (e.g., inflammation, oxidative stress,
and hyperglycemia) is likely to trigger both. Oxidative
stress due to acutely induced hyperglycemia resulted in
increased urine GST expression in a mouse model [31].
Recurrence of such events could in time lead to enzymatic
exhaustion. Diabetic subjects with decreased π-GST acti-
vity are less likely to cope with oxidative stress and, there-
fore, could more easily develop generalized vascular injury
and endothelial dysfunction [32].
Tamm-Horsfall protein appears to rise with increasing
diabetes duration, whereas urine albumin excretion, a
more conventional marker for the development of ne-
phropathy, remains normal [33]. This may explain why
in this study THP was not associated with diabetic, in-
flammatory or vascular markers.
Study limitations: π GST was measured in urine, not in
the blood or the cytosolic of renal cells, making thus diffi-
cult the interpretation of the precise meaning of our fin-
dings. This issue needs to be addressed in future studies.
Conclusions
In conclusion, the findings suggest that, in young patients
with type1 diabetes, lower levels of π-GST:crea ratio cor-
relate with changes in arterial structure and microvascular
function. Future prospective studies are warranted to assess
whether urine levels of π-GST could be used as biomarker
for kidney disease in young patients with type 1 diabetes,
and to clarify the above associations.
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